Ezeibe, M.C.O., Ezeobele, O.K., Esen, M.E., Ngene, A.A., et al. (2013) Synergy on Antibacterial Activities of Ampicilin trihydrate, Stabilized with a Synthetic Ammonium-Stimulant, a Resistant Escherichia coli Infection. Health, 5, 1548-1552.
https://doi.org/10.4236/health.2013.510210

has been cited by the following article:

• TITLE: Restoring Efficacy to Cotrimoxazole, against Resistant Salmonella pullorum, with Medicinal Synthetic Aluminum-Magnesium Silicate ® [MSAMS: Al4 (SiO4)3 + 3Mg2SiO4 → 2Al2 Mg3 (SiO4)3]

  AUTHORS: Maduike Chiehiura Onwubiko Ezeibe, Aniefiok Emerson Udom, Obiageri Favour Onyeachonam, Ijeoma Joy Ogbonna

  KEYWORDS: Cure for Resistant Infections, Salmonellosis, MSAMS

  JOURNAL NAME: Health, Vol.11 No.9, September 27, 2019

  ABSTRACT: To restore efficacy (≥95% infection-reduction) to drugs against resistant infections (now, posing a bigger medical challenge, globally, than even HIV/AIDS), Cotrimoxazole was formulated with a synthetic Aluminum-magnesium silicate (Medicinal mineral which molecules are made of Nanoparticles, that is already in use as pharmaceutical-stabilizing agent) and used with antioxidants to treat Cotrimoxazole-resistant Salmonella pulorum infected chicks. Chick-groups A, B and C were fed antioxidants-fortified feed while groups D, E, F, G and H were not. The treatment-groups and their Cotrimoxazole doses/formulations were: A and D (100%/MSAMS-Cotrimoxazole); B and E (75%/MSAMS-Cotrimoxazole); C and F (50%/MSAMS-Cotrimoxazole) and G (100%/Cotrimoxazole). Infection-reductions (96.23% and 94.98%) of the groups of 75%/MSAMS-Cotrimoxazole/antioxidants and 75%/MSAMS-Cotrimoxazole were significantly (P ≤ 0.05) better than 76.99% (100%/Cotrimoxazole); 10.04% (50%/MSAMS-Cotrimoxazole/antioxidants); 1.60% (50%/MSAMS-Cotrimoxazole); −212.60% (100%/MSAMS-Cotrimoxazole/antioxidants) and −230.96% (100%/MSAMS-Cotrimoxazole).